Chapter

Proteomics and Biomarkers

Gwenael Pottiez, Jayme Wiederin and Pawel Ciborowski

in The Neurology of AIDS

Third edition

Published on behalf of Oxford University Press

Published in print December 2011 | ISBN: 9780195399349
Published online September 2012 | e-ISBN: 9780199965199 | DOI: http://dx.doi.org/10.1093/med/9780195399349.003.0062
Proteomics and Biomarkers

More Like This

Show all results sharing these subjects:

  • Disorders of the Nervous System
  • Infectious Diseases

GO

Show Summary Details

Preview

Proteome, a term that was created from the combination of "protein" and "genome," refers to the entire set of proteins expressed by a genome, cell, or tissue under a specified set of conditions. Just as genomics refers to the study of genes or genomes, so proteomics refers to the study of proteins or proteomes. More specifically, proteomics is the global study of the expression, localizations, functions, and interactions of proteins in any biological system. Proteomics emerged in the mid-1990s as a separate scientific field due to a rapid advancement in analytical technologies that made possible the reliable identification of multiple proteins simultaneously from the same biological sample. A biomarker, broadly defined, is any identifiable feature that reflects quantitative changes in a biological system. Biomarkers can indicate changes relevant to any aspect of a biological process or disease. This chapter explores the use of proteins, identified through proteomic methods, as biomarkers in the study and clinical management of HIV-associated disease. The particular focus is HIV-associated central nervous system disease.

Chapter.  9308 words.  Illustrated.

Subjects: Disorders of the Nervous System ; Infectious Diseases

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.